Auriga Laboratories (ARGA) DEFA14A Additional proxy soliciting materials

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No.  )

Filed by the Registrantþ
Filed by a Party other than the Registranto

Check the appropriate box:

o Preliminary Proxy Statement

o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

o Definitive Proxy Statement

þ Definitive Additional Materials

o Soliciting Material Pursuant to §240.14a-12

AURIGA LABORATORIES, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

þ No fee required.

o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1)	Title of each class of securities to which transaction applies:
(2)	Aggregate number of securities to which transaction applies:
(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
(4)	Proposed maximum aggregate value of transaction:
(5)	Total fee paid:

o Fee paid previously with preliminary materials.

o Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1)	Amount Previously Paid:
(2)	Form, Schedule or Registration Statement No.:
(3)	Filing Party:
(4)	Date Filed:

Addendum dated June 15, 2007

On May 11, 2007, Auriga Laboratories, Inc. (the Company”) mailed to its stockholders the Definitive Proxy Statement ( the “Proxy Statement”).

The Proxy Statement states, at page 3, that the directors will be elected by a plurality of votes. In addition, the Proxy Statement states, at page 7, that the five director nominees receiving the greatest number of votes will be elected (which is a description of how plurality voting operates, when applicable, under Delaware law). These statements are erroneous. Section 2.3(b) of the Company’s Bylaws provides that the directors will be elected by a majority of the votes cast at the meeting. A copy of the Bylaws was included as Appendix C to the Company’s definitive proxy statement for its special meeting of stockholders held on July 8, 2006, and has been incorporated by reference as an exhibit to the Company’s Annual Report on Form 10-KSB for the year ended December 31, 2006.

The information provided above may be deemed “additional soliciting materials” within the meaning of the Securities Exchange Act of 1934, as amended. The Proxy Statement, which we urge you to read in its entirety, is amended and supplemented by, and should be read as part of, and in conjunction with, the information set forth herein.